Evidence map›Paper›PMID 37051183›Full record

ArticleTheScientificWorldJournal2023

eEF1A2 siRNA Suppresses MPP

Kawinthra Khwanraj, Athinan Prommahom, Permphan Dharmasaroja

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in TheScientificWorldJournal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Alpha-Mangostin Alleviates Mitochondrial Damage and Autophagy Dysregulation in the MPPAdvances in pharmacological and pharmaceutical sciences · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Kawinthra KhwanrajDepartment of Anatomy, Faculty of Science, Mahidol University, Bangkok, Thailand.ORCID https://orcid.org/0000-0002-6324-9992
Athinan PrommahomChakri Naruebodindra Medical Institute, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Samut Prakan, Thailand.ORCID https://orcid.org/0000-0003-1792-8449
Permphan DharmasarojaDepartment of Anatomy, Faculty of Science, Mahidol University, Bangkok, Thailand.ORCID https://orcid.org/0000-0003-1557-8940
Mahidol University · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The tissue-specific protein eEF1A2 has been linked to the development of neurological disorders. The role of eEF1A2 in the pathogenesis of Parkinson's disease (PD) has yet to be investigated. The aim of this study was to determine the potential neuroprotective effects of eEF1A2 in an MPP

Indexed as

NeuroblastomaParkinson Disease1-Methyl-4-phenylpyridiniumApoptosisCaspase 3Cell Line, TumorHumansMechanistic Target of Rapamycin Complex 1Peptide Elongation Factor 1Phosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktRNA, Small InterferingTOR Serine-Threonine KinasesTumor Suppressor Protein p531-Methyl-4-phenylpyridiniumCaspase 3EEF1A2 protein, humanMechanistic Target of Rapamycin Complex 1MTOR protein, humanPeptide Elongation Factor 1Phosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktRNA, Small InterferingTOR Serine-Threonine KinasesTumor Suppressor Protein p53

Identifiers

PMID37051183
PMCPMC10085650
OpenAlexW4362575012

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.